Cravatex Limited (NSE:CRAVATEX)
India · Delayed Price · Currency is INR 336.60
-7.20 (-2.09%)
At close: Nov 9, 2026
Cravatex Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,620 | 1,509 | 1,738 | 2,026 | 5,037 | 5,943 |
Other Revenue | 122.61 | 134.94 | 59.52 | 133.03 | 71.25 | 86.94 |
| 1,742 | 1,644 | 1,797 | 2,159 | 5,108 | 6,030 | |
Revenue Growth | -1.48% | -8.54% | -16.77% | -57.73% | -15.30% | 10.74% |
Cost of Revenue | 803.67 | 762.53 | 1,061 | 1,395 | 3,638 | 4,142 |
Gross Profit | 938.82 | 881.16 | 735.75 | 764.24 | 1,469 | 1,888 |
Selling, General & Admin | 420.46 | 418.73 | 345.38 | 376.75 | 832.92 | 909.68 |
Other Operating Expenses | 428.25 | 391.28 | 346.83 | 330.81 | 863.29 | 919.74 |
Operating Expenses | 863.76 | 825.09 | 706.99 | 726.39 | 1,858 | 1,993 |
Operating Income | 75.06 | 56.06 | 28.76 | 37.85 | -388.29 | -104.8 |
Interest Expense | -3.32 | -3.56 | -4.05 | -3.96 | -133.6 | -134.78 |
Interest & Investment Income | 32.21 | 32.21 | 39.5 | 27.73 | 16.27 | 9.85 |
Currency Exchange Gain (Loss) | - | - | - | - | -4.32 | -2.63 |
Other Non Operating Income (Expenses) | - | - | - | - | - | 0.08 |
EBT Excluding Unusual Items | 103.95 | 84.71 | 64.22 | 61.62 | -509.94 | -232.29 |
Gain (Loss) on Sale of Investments | 1.04 | 1.04 | 0.44 | 0.13 | 28.67 | 47.25 |
Gain (Loss) on Sale of Assets | - | - | - | 0.12 | 7.5 | -0.39 |
Asset Writedown | - | - | -0.93 | -0.25 | - | - |
Other Unusual Items | - | - | - | - | 1,057 | - |
Pretax Income | 104.99 | 85.76 | 63.72 | 61.6 | 583.33 | -185.44 |
Income Tax Expense | 24.91 | 17.79 | 15.44 | 13.33 | -5.99 | 13.44 |
Earnings From Continuing Operations | 80.08 | 67.97 | 48.28 | 48.28 | 589.33 | -198.88 |
Minority Interest in Earnings | - | - | - | - | - | 0.01 |
Net Income | 80.08 | 67.97 | 48.28 | 48.28 | 589.33 | -198.87 |
Net Income to Common | 80.08 | 67.97 | 48.28 | 48.28 | 589.33 | -198.87 |
Net Income Growth | 44.48% | 40.77% | 0.02% | -91.81% | - | - |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Change | -0.02% | - | - | - | - | - |
EPS (Basic) | 30.99 | 26.30 | 18.68 | 18.68 | 228.05 | -76.96 |
EPS (Diluted) | 30.99 | 26.30 | 18.68 | 18.68 | 228.05 | -76.96 |
EPS Growth | 44.51% | 40.77% | 0.02% | -91.81% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 152.97 | 8.72 | 12.09 | 180.45 | 1,435 | -92.72 |
Free Cash Flow Per Share | 59.20 | 3.37 | 4.68 | 69.83 | 555.46 | -35.88 |
Dividend Per Share | 13.000 | 13.000 | 12.500 | 3.000 | 1.500 | 3.000 |
Dividend Growth | 4.00% | 4.00% | 316.67% | 100.00% | -50.00% | 0% |
Gross Margin | 53.88% | 53.61% | 40.94% | 35.39% | 28.77% | 31.31% |
Operating Margin | 4.31% | 3.41% | 1.60% | 1.75% | -7.60% | -1.74% |
Profit Margin | 4.60% | 4.13% | 2.69% | 2.24% | 11.54% | -3.30% |
Free Cash Flow Margin | 8.78% | 0.53% | 0.67% | 8.36% | 28.10% | -1.54% |
EBITDA | 83.87 | 64.9 | 37.26 | 45.91 | -313.17 | -26.16 |
EBITDA Margin | 4.81% | 3.95% | 2.07% | 2.13% | -6.13% | -0.43% |
D&A For EBITDA | 8.81 | 8.83 | 8.5 | 8.06 | 75.13 | 78.64 |
EBIT | 75.06 | 56.06 | 28.76 | 37.85 | -388.29 | -104.8 |
EBIT Margin | 4.31% | 3.41% | 1.60% | 1.75% | -7.60% | -1.74% |
Effective Tax Rate | 23.72% | 20.75% | 24.22% | 21.63% | - | - |
Revenue as Reported | 1,776 | 1,677 | 1,837 | 2,187 | 5,161 | 6,043 |
Advertising Expenses | - | 49.62 | 34.76 | 49.81 | 170.25 | 196.98 |